Company Overview of Itero Biopharmaceuticals, Inc.
Itero Biopharmaceuticals, Inc. develops, manufactures and commercializes recombinant DNA-produced protein therapeutics. It provides recombinant follicle stimulating hormone for the treatment of female infertility. The company has a strategic partnership with Watson Pharmaceuticals, Inc. The company was founded in 2006 and is based in San Mateo, California. It has an additional location in Mountain View, California. Itero Biopharmaceuticals, Inc. operates as a subsidiary of Itero Biopharmaceuticals, LLC.
155 Bovet Road
San Mateo, CA 94402
Founded in 2006
Key Executives for Itero Biopharmaceuticals, Inc.
Similar Private Companies By Industry
|OrthoCyte Corporation||United States|
|Trophogen, Inc.||United States|
|Cognate TiGenix||United States|
|Carigent Therapeutics, Inc.||United States|
|Centocor Biologics, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Itero Biopharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.